Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction

Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction

Background: Two-Drug Regimens (2DR) have proven effective in clinical trials but real-world data, especially in resource-limited settings, is limited. Objectives: To evaluate viral suppression of lamivudine-based 2DR, with dolutegravir or ritonavir-boosted protease inhibitor (lopinavir/r, atazanavir...

Full description

Bibliographic Details
Main Authors: Elaine Monteiro Matsuda, Ivana Barros Campos, Isabela Penteriche de Oliveira, Daniela Rodrigues Colpas, Giselle Ibete Silva López-Lopes, Victor Oliveira Chiavegato, Luís Fernando de Macedo Brígido
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
HIV-1
2DR
Dual therapy
3TC resistance
CKD-EPI
Online Access:http://www.sciencedirect.com/science/article/pii/S141386702300017X

Internet

http://www.sciencedirect.com/science/article/pii/S141386702300017X

Similar Items